How Can We Improve Patient-Clinician Communication for Men Diagnosed with Prostate Cancer?
The ability of health care professionals to communicate with patients compassionately and effectively is crucial for shared decision-making, but littl…
The ability of health care professionals to communicate with patients compassionately and effectively is crucial for shared decision-making, but littl…
Available online 5 March 2024, 101344 Author links open overlay panel Ziad A. Ali MD, DPhil a, Antonio Dager MD b, Mauricio Zúñiga MD b,…
DD01 is a long-acting dual agonist of glucagon-like peptide-1 and glucagon receptors.
Little is known about the effect tubulointerstitial nephropathies have in modulating maternal-fetal outcomes in pregnancy. Therefore, we analyzed the …
Available online 21 August 2023, 101121 Author links open overlay panel Rajesh V. Swaminathan MD, FSCAI (Vice-Chair) a, Cara Anne East MD b, Dmitriy N.…
Neal D. Shore, MD, shares what he’s most looking forward to at this year’s American Urological Association Annual Meeting.
Adding the radionuclide therapy ¹⁷⁷Lu-PSMA-617 to enzalutamide improved outcomes in patients with treatment-naïve mCRPC in a phase 2 trial.
Topic: Implementation Science in Urologic Oncology: Translating Evidence into Practice Symposium Goal: To introduce Implementation Science to those new to the field, highlight how implementation…
Percutaneous revascularization is the primary strategy for treating lower extremity venous and arterial disease. Angiography is limited by its ability…
Alicia Morgans presents a meta-analysis, undertaken with colleagues, analyzing 14 phase three trials on treatment intensification in metastatic hormone-sensitive prostate cancer. The study scrutinizes outcomes…
Investigators assessed the monosodium urate burden using 2 ultrasound scoring systems among patients with gout and compared their ability to predict flares.